Anest. intenziv. Med. 2005;16(1):18-20

Co je nového ve farmakoterapii bolesti?Algeziology

P. Ševčík, M. Hakl, R. Hřib
Anesteziologicko-resuscitační klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice u sv. Anny v Brně

V posledním desetiletí se také na našem trhu objevily silné opioidy v lékových formách, které umožňují dlouhodobé podávání v léčbě chronické onkologické i nenádorové bolesti.

Published: February 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ševčík P, Hakl M, Hřib R. Co je nového ve farmakoterapii bolesti? Anest. intenziv. Med. 2005;16(1):18-20.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Allan, L., Hays, H., Jensen, N. H. et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine by treating chronic non-cancer pain. BMJ, 2001, 322, p. 1154-1158. Go to original source... Go to PubMed...
    2. Bailer, M., Johannessen, S. I., Kupfeberg, H. J. et al. Progress report on new antiepileptic drugs: a summary of the Fourth Eilat Conference (EILAT IV). Epilepsy Res., 1999, 34, p.1-41. Go to original source... Go to PubMed...
    3. Clark, A. J., Ahmedzai, S. H., Allan, L. G. et al. Efficacy and safety of transdermal fentanyl and sustaned-release oral morphine in patients with cancer and chronic non-cancer pain. Curr. Med. Res. Opin., 2004, 20, p. 1419-1428. Go to original source... Go to PubMed...
    4. Clark, A. J., Allan, L. G., Horbay, G. L. A. et al. Transdermal fentanyl (TDF) is significantly better than sustained release morphine (SRM) in managing chronic pain: a meta-analysis in cancer and in chronic non-cancer pain. J. Pain, 2004, 5, S1.
    5. Deleminj, P. L. I., van Duijn, H., Vanneste, J. A. L.: Prolonged treatment with transdermal fentanyl in neuropatic pain. J. Pain Symptom Manage., 1998, 16, p. 220-229. Go to original source... Go to PubMed...
    6. Dizdar, Y., Kucucuk, S., Kaytan, E. et al. Evaluation of the clinical efficacy of transdermal fentanyl (Durogesic) in adults with cancer-related pain: an open multicentre study, on behalf of Durogesic Mewa Working Group. Pain in Europe IV - 4th Congress of the European Federation of IASP Chapters (EFIC), Prague 2003, 300 p.
    7. Donner, B., Zenz, M., Tryba, M. et al. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. J. Pain, 1996, 64, p. 527-534. Go to original source... Go to PubMed...
    8. Dworkin, R. H., Corbin, A. E., Young jr., J. P. et al. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology, 2003, 60, p. 1274-1283. Go to original source... Go to PubMed...
    9. Hagen, N. A., Thirlwell, M. P., Dhaliwal, H. S. et al. Steadystate pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled release hydromorphone. J. Clin. Pharmacol., 1995, 35, p. 37-44. Go to original source... Go to PubMed...
    10. Hanks, G. W., Wand, P. J. Enterohepatic circulation of opioid drugs. It is clinically relevant in the treatment of cancer patients. Clin. Pharmacokinet., 1989, 17, p. 65-68. Go to original source... Go to PubMed...
    11. Hennies, H. H., Friderichs, E., Schneider, J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneim-Forsch/Drug Res., 1988, 38, s. 877-880.
    12. Jaffe, J. H., Martin, W. R. Opioid analgesics and antagonists. In Goodmann, G. A., Godmann, L. S., Rall, T. W., Murad, F. (eds): The Pharmacological basis of Therapeutics. 7th ed. New York : MacMillan 1985, p. 491-531.
    13. Jones, D. L., Sorkin, L. S. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia. Brain Res., 1998, 81, p. 93-99. Go to original source... Go to PubMed...
    14. Langford, R., Ratcliffe, S., McKenna, F., Sevcik, P., Szechinski, J., Vojtassak J. Effects of transdermal fentanyl on pain and functioning in osteoarthritis: a randomized, double-blind, placebo-controlled trial. Pain Practice, Book of Abstracts, 2004, 285 p. Go to original source...
    15. Menten, J., Desmedt, M., Lossignol, D., Mulllie, A. Longitudinal follow-up of TTS-fentanyl in patients with cancer related pain: results of a compassionate-use study with special focus on elderly patients. Cur. Med. Opin., 2002, 178, p. 488-498. Go to original source... Go to PubMed...
    16. Moriarty, M., McDonald, C. J., Miller, A. J. A randomised crossover comparison of controlled release hydromorphone tablets with controlled release morphine tablets in patients with cancer pain. J. Clin. Res., 1999, 2, p. 1-8.
    17. Mystakidou, K., Parpa, E., Tsililka, E. et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J. Pain, 2003, 4, p. 298-306. Go to original source... Go to PubMed...
    18. Newshan, G., Lefkowitz, M. Transdermal fentanyl for chronic pain in AIDS: a pilot study. J. Pain Symprom Manage., 2001, 21, p. 69-77. Go to original source... Go to PubMed...
    19. Persoli-Gudelj, M., Loncaric-Katusin, M. Long-term treatment of non-cancer pain with transdermal fentanyl (Durogesic). Poster at Pain in Europe IV - 4th Congress of the European Federation of IASP Chapters (EFIC), Prague 2003.
    20. Radbruch, L., Sabatowski, R., Loick, G. et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine. Palliat. Med., 2000, 14, p. 111-119. Go to original source... Go to PubMed...
    21. Sabatowski, R., Galvez, R., Cherry, D. A. et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain, 2004, 109, p. 26-35. Go to original source... Go to PubMed...
    22. Sohn, W. Hydromorphon - ein starkes Opioid mit Vorteilen bei der Verstoffwechselung. Fortschritte der Medizin, 2003, 121, s. 51-55.
    23. Ševčík, P. Buprenorphinum. Remedia, 2003, 13, s. 360-370.
    24. van Seventer, R., Smit, J., Schipper, R. et al. Comparison of TTS fentanyl with sustained-released oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. Curr. Med. Res. Opin., 2003, 19, p. 457-469. Go to original source... Go to PubMed...
    25. Zenz, M., Gupta, S., Clark, A. J, Freynhagen, R. How can new patch technology improve pain management? 3rd World Congress World Institute of Pain, Barcelona, 2004, p. 1-11.

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.